553 results on '"Poulin, Yves"'
Search Results
2. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management
3. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part I: Diagnosis, evaluation, and the use of complementary and procedural management
4. Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel
5. Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology
6. Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis
7. Psoriasis Prevalence and Severity by Expert Elicitation
8. TYK2/JAK1 Inhibitor PF-06700841 in Patients with Plaque Psoriasis: Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial
9. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
10. A Phase 2 Randomized Trial of Apremilast in Patients with Atopic Dermatitis
11. Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
12. Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
13. Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
14. Serious infections in patients with self-reported psoriatic arthritis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) treated with biologics
15. La gestion de projets de développement international et d’action humanitaire 2e édition
16. Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, versus placebo and apremilast in moderate to severe plaque psoriasis: analysis of body surface area involvement in the phase 3 POETYK PSO-1 and PSO-2 trials
17. Psychometric properties of the French Female Sexual Function Index (FSFI)
18. Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis
19. Evaluation of the French version of the 4-item index of the Acne-QoL (AcneQ4fr)
20. Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study
21. Enhancing public governance in fragile states: Support for Haiti
22. Management of acne: Canadian clinical practice guideline
23. Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II
24. Health-Related Quality of Life Worsens Disproportionately to Objective Signs of Psoriasis After Withdrawal of Adalimumab Therapy
25. Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology
26. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
27. Evidence that a neutrophil–keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis
28. Serious infection events in the Psoriasis Longitudinal Assessment and Registry Study (PSOLAR): Current status of observations: 1643
29. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe plaque psoriasis: Pooled 16-week efficacy in patient subgroups (ESTEEM 1 and 2): 1099
30. Safety of follow-up field application of ingenol mebutate 0.015% gel for actinic keratoses on face and scalp: 604
31. 26237 Baricitinib, an oral, reversible Janus kinase-1 and -2 inhibitor, for atopic dermatitis: Head and neck response from BREEZE-AD5
32. A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab
33. La gestion de projets de développement international et d'action humanitaire Ed. 2
34. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial
35. Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
36. Prevalence and severity of facial and truncal acne in a referral cohort
37. Supplementary Material 1 - Supplemental material for Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
38. Supplementary Material 2 - Supplemental material for Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
39. XP-828L in the treatment of mild-to-moderate psoriasis: a randomized, double-blind, placebo-controlled study
40. Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis
41. Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches
42. A favourable benefit/risk ratio with efalizumab: A review of the clinical evidence
43. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris
44. La gestion de projets de développement international et d’action humanitaire 2e édition
45. Practical Approach to the Hormonal Treatment of Acne
46. Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert Panel
47. The Use of Alefacept in the Treatment of Psoriasis
48. Incorporating Biologics into the Treatment of Psoriasis
49. Pathogenesis of Psoriasis and Current Challenges
50. Facial Lipoatrophy Following Systemic Lupus Erythematosus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.